Syngene and John Hopkins University to advance drug discovery
Syngene International has announced a strategic collaboration with John Hopkins University to advance early-stage drug discovery programmes. The collaboration will incorporate Syngene’s SynVent, a fully integrated drug discovery and development platform that spans discovery biology, medicinal and synthetic chemistry, DMPK (Drug Metabolism and Pharmacokinetics), toxicology, and early development. … Read More